top of page
Search

Sunrise Device for Screening and Diagnosis of Sleep Apnoea

Updated: Jan 29

The Sunrise device is an innovative screening and diagnostic device designed to aid in the efficient diagnosis of sleep apnoea syndrome, a common yet often underdiagnosed sleep disorder. This summary outlines how the Sunrise device can support streamlining of the diagnostic pathway and potentially reduce waiting times for more comprehensive sleep studies within the NHS. 1-3.


Key Features and Benefits:


1. Home-Based Monitoring: The Sunrise device allows patients to carry out sleep studies from the comfort of their homes. This approach reduces the need for overnight stays in sleep centres, minimising patient inconvenience and hospital resource usage.


2. Non-Invasive: Patients wear the small 3 g sensor device on the tip of their chin while sleeping, and it collects valuable data such as respiratory disturbance events, number of breathing pauses, sleep position, sleep staging, sleep patterns and total sleep time without the need for invasive procedures.


3. Accurate Data: Sunrise utilises machine learning and Artificial Intelligence in its advanced sensor to capture comprehensive sleep data, and automated analysis of the data ensuring reliable results for clinicians to evaluate.


4. Timely Diagnosis: With the data collected by the Sunrise device, clinicians can often make a preliminary diagnosis of sleep apnoea more quickly than traditional in-lab studies, expediting patient care.


5. Reduced NHS Waiting Times: By triaging patients with suspected sleep apnoea using the Sunrise device, healthcare providers can prioritise those who require more detailed in-lab testing, reducing waiting times for patients in need of more specialised sleep tests.


Clinical Applications:


1. Screening: The Sunrise device serves as an effective screening tool to identify individuals at risk of sleep apnoea. Those with positive results can be promptly referred for further evaluation.


2. Diagnosis Confirmation: For patients with suspected sleep apnoea, the Sunrise device can provide initial diagnostic data, enabling healthcare providers to confirm the condition and initiate treatment sooner.


3. Treatment Monitoring: The device can also be used to monitor treatment efficacy, ensuring that interventions such as continuous positive airway pressure (CPAP) therapy are effectively addressing the sleep disorder.




The Sunrise device is an innovative technology advancement in the field of sleep medicine. By facilitating home-based sleep studies and providing accurate data, it has the potential to expedite the diagnosis of sleep apnoea syndrome and reduce waiting times within the NHS for more detailed testing. Clinicians can confidently incorporate this tool into their clinical pathway to improve patient care and outcomes.


References:


1. Pepin JL, Le-Dong NN, Cuthbert V, Coumans N, Tamisier R, Malhotra A, Martinot JB. Mandibular Movements are a Reliable Noninvasive Alternative to Esophageal Pressure for Measuring Respiratory Effort in Patients with Sleep Apnea Syndrome. Nat Sci Sleep. 2022 Apr 13;14:635-644. doi: 10.2147/NSS.S346229. PMID: 35444480; PMCID: PMC9013709.


2. Malhotra A, Martinot JB, Pépin JL. Insights on mandibular jaw movements during polysomnography in obstructive sleep apnea. Journal of Clinical Sleep Medicine. 2023 Sep 28:jcsm-10830.


3. Martinot JB, Le-Dong NN, Malhotra A, Pépin JL. Respiratory effort during sleep and prevalent hypertension in obstructive sleep apnoea. European Respiratory Journal. 2023 Mar 1;61(3).


Comentarios


bottom of page